Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00408733 · ClinicalTrials.gov registry record · NA

Evaluating a Low-Literacy Discharge Medication Education Tool

A NA study of Coronary Artery Disease and Congestive Heart Failure, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
287
Enrollment target
1
Study location

NCT00408733 is a NA study of Coronary Artery Disease and Congestive Heart Failure that has completed, run by University of California, Los Angeles. The registered enrollment target is 287 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00408733, a NA study of Coronary Artery Disease and Congestive Heart Failure, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
287 participants
Enrollment target
1
Study location

Study Summary

Recent studies have demonstrated that patients sub-optimally understand hospital discharge medication instructions Health literacy has been shown to be an important factor in patient understanding of medical information , and following medication instructions. The primary aim of this project is to test the efficacy of a low-literacy discharge medication education tool on medication adherence, and patient knowledge and understanding of inpatient discharge medications, in a low-income population with low health literacy levels. This evaluation is a prospective trial with patients randomly assigned to either receiving this tool or receiving the current standard of care. Given the complexity of the discharge medication regimen for the conditions of congestive heart failure (CHF) and coronary artery disease (CAD), and the proven effectiveness of these medications in the post discharge period, this trial will focus on the subpopulation of patients hospitalized with these two conditions.

Conditions Studied

Coronary Artery Disease Congestive Heart Failure

Interventions

  • OTHER Medication Education Tool

Study Locations (1)

California

  • Los Angeles County/ USC Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 287 participants
Start Date 2007-01
Est. Completion 2007-08
Phase NA

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00408733

The ClinicalTrials.gov registry entry for NCT00408733 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 287 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (78% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Medication Education Tool is the first listed.

NCT00408733 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00408733 about?

NCT00408733 is a clinical study titled "Evaluating a Low-Literacy Discharge Medication Education Tool". Recent studies have demonstrated that patients sub-optimally understand hospital discharge medication instructions Health literacy has been shown to be an important factor in patient understanding of medical information , and following medication instructions. The primary aim of this project is to ...

What is the current status of trial NCT00408733?

This trial is currently completed. It is a NA study. The enrollment target is 287 participants. The study started on 2007-01. Estimated completion is 2007-08.

What conditions does trial NCT00408733 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Congestive Heart Failure.

What interventions are being tested in trial NCT00408733?

The interventions under investigation include: Medication Education Tool (OTHER).

Who is sponsoring clinical trial NCT00408733?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00408733 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Congestive Heart Failure

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.